Skip to main content

Anton Pottegård

Cancer informatics

Phone: +45 6550 3024
Webpage: Anton Pottegård


Department and Faculty
Department of Public Health, Faculty of Health Sciences

My current portfolio includes a Sapere Aude Young Research Leader grant from the Danish Independent Research Council with other research activities funded by other Danish funds such as the Velux Foundation, Helsefonden, and several regional funds. Finally, I serve as PI for several large-scale contracts for regulator-mandated phase IV-studies funded by the industry with funds paid to my institution.

Research vision
I am a pharmacoepidemiologist and clinical pharmacist working at the University of Southern Denmark. My research focuses on the use of drugs in its broadest sense. Typically, I use data from Danish or international health care registries, to either identify new side effects to drugs or better characterize known ones.

Three key publications 
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca vaccine in Denmark and Norway: Population based cohort study 
Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, Lidegaard Ø, Tapia G, Gulseth HL, Ruiz PL, Watle SV, Mikkelsen AP, Pedersen L, Sørensen HT, Thomsen RW, Hviid A
BMJ. 2021 May 5;373:n1114.
doi: 10.1136/bmj.n1114.

Use of N-nitrosomethylamine (NDMA) contaminated valsartan products and risk of cancer: A Danish nationwide cohort study
Pottegård A, Kristensen KB, Ernst MT, Johansen NB, Quartarolo P, Hallas J. 
BMJ. 2018 Sep 12;362:k3851
doi: 10.1136/bmj.k3851.

Association of hydrochlorothiazide use and risk of malignant melanoma
Pottegård A, Pedersen SA, Schmidt SAJ, Hölmich LR, Friis S, Gaist D. 
JAMA Intern Med. 2018 Aug 1;178(8):1120-1122
doi: 10.1001/jamainternmed.2018.1652.